Maternal environment interacts with modifier genes to influence progression of nephrotic syndrome

Journal of the American Society of Nephrology

Volumn 19, Issue 8, 2008, Pages 1491-1499

  Ratelade, Julien ^a,b   Lavin, Tiphaine Aguirre ^a,b   Muda, Andrea Onetti ^a,e   Morisset, Ludivine ^a,b   Mollet, Géraldine ^a,b   Boyer, Olivia ^a,b   Chen, Deborah S ^a,b   Henger, Anna ^f   Kretzler, Matthias ^f   Hubner, Norbert ^g   Théry, Clotilde ^c   Gubler, Marie Claire ^a,b   Montagutelli, Xavier ^d   Antignac, Corinne ^a,b   Esquivel, Ernie L ^a,b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUT CURIE   (France)

^d INSTITUT PASTEUR   (France)

^e UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; PODOCIN; POTASSIUM; UREA; MEMBRANE PROTEIN; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 3; CHROMOSOME 7; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE INACTIVATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC LINKAGE; KIDNEY DISEASE; MALE; MOTHER FETUS RELATIONSHIP; MOUSE; NEPHROTIC SYNDROME; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEINURIA; QUANTITATIVE TRAIT LOCUS MAPPING; ANIMAL; ENVIRONMENT; GENETICS; GENOMICS; KIDNEY; PATHOLOGY;

ANIMALS; DISEASE PROGRESSION; ENVIRONMENT; FEMALE; GENOMICS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MALE; MEMBRANE PROTEINS; MICE; NEPHROTIC SYNDROME; PHENOTYPE;

EID: 49649115589     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007111268     Document Type: Article

References (40)

1. Roselli S, Gribouval O, Boute N, Sich M, Benessy F, Attie T, Gubler MC, Antignac C: Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol 160: 131-139, 2002
2. Huber TB, Kottgen M, Schilling B, Walz G, Benzing T: Interaction with podocin facilitates nephrin signaling. J Biol Chem 276: 41543-41546, 2001
3. Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W, Shaw AS, Holzman LB, Mundel P: Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 108: 1621-1629, 2001
4. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24: 349-354, 2000
5. Weber S, Gribouval O, Esquivel EL, Moriniere V, Tete MJ, Legendre C, Niaudet P, Antignac C: NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low posttransplant recurrence. Kidney Int 66: 571-579, 2004
6. Fuchshuber A, Gribouval O, Ronner V, Kroiss S, Karle S, Brandis M, Hildebrandt F: Clinical and genetic evaluation of familial steroid-responsive nephrotic syndrome in childhood. J Am Soc Nephrol 12: 374-378, 2001
7. Karle SM, Uetz B, Ronner V, Glaeser L, Hildebrandt F, Fuchshuber A: Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13: 388-393, 2002
8. Caridi G, Bertelli R, Di Duca M, Dagnino M, Emma F, Onetti Muda A, Scolari F, Miglietti N, Mazzucco G, Murer L, Carrea A, Massella L, Rizzoni G, Perfumo F, Ghiggeri GM: Broadening the spectrum of diseases related to podocin mutations. J Am Soc Nephrol 14: 1278-1286, 2003
9. Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F: Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 15: 722-732, 2004
10. Roselli S, Heidet L, Sich M, Henger A, Kretzler M, Gubler MC, Antignac C: Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol 24: 550-560, 2004
11. Mrug M, Li R, Cui X, Schoeb TR, Churchill GA, Guay-Woodford LM: Kinesin family member 12 is a candidate polycystic kidney disease modifier in the cpk mouse. J Am Soc Nephrol 16: 905-916, 2005
12. Woo DD, Nguyen DK, Khatibi N, Olsen P: Genetic identification of two major modifier loci of polycystic kidney disease progression in pcy mice. J Clin Invest 100: 1934-1940, 1997
13. Andrews KL, Mudd JL, Li C, Miner JH: Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome. Am J Pathol 160: 721-730, 2002
14. Gharavi AG, Ahmad T, Wong RD, Hooshyar R, Vaughn J, Oller S, Frankel RZ, Bruggeman LA, D'Agati VD, Klotman PE, Lifton RP: Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. Proc Natl Acad Sci U S A 101: 2488-2493, 2004
15. Zheng Z, Schmidt-Ott KM, Chua S, Foster KA, Frankel RZ, Pavlidis P, Barasch J, D'Agati VD, Gharavi AG: A Mendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse. Proc Natl Acad Sci U S A 102: 2502-2507, 2005
16. Zheng F, Plati AR, Potier M, Schulman Y, Berho M, Banerjee A, Leclercq B, Zisman A, Striker LJ, Striker GE: Resistance to glomerulosclerosis in B6 mice disappears after menopause. Am J Pathol 162: 1339-1348, 2003
17. Pillebout E, Burtin M, Yuan HT, Briand P, Woolf AS, Friedlander G, Terzi F: Proliferation and remodeling of the peritubular microcirculation after nephron reduction: Association with the progression of renal lesions. Am J Pathol 159: 547-560, 2001
18. Churchill GA, Doerge RW: Empirical threshold values for quantitative trait mapping. Genetics 138: 963-971, 1994
19. Abiola O, Angel JM, Avner P, Bachmanov AA, Belknap JK, Bennett B, Blankenhorn EP, Blizard DA, Bolivar V, Brockmann GA, Buck KJ, Bureau JF, Casley WL, Chesler EJ, Cheverud JM, Churchill GA, Cook M, Crabbe JC, Crusio WE, Darvasi A, de Haan G, Dermant P, Doerge RW, Elliot RW, Farber CR, Flaherty L, Flint J, Gershenfeld H, Gibson JP, Gu J, Gu W, Himmelbauer H, Hitzemann R, Hsu HC, Hunter K, Iraqi FF, Jansen RC, Johnson TE, Jones BC, Kempermann G, Lammert F, Lu L, Manly KF, Matthews DB, Medrano JF, Mehrabian M, Mittlemann G, Mock BA, Mogil JS, Montagutelli X, Morahan G, Mountz JD, Nagase H, Nowakowski RS, O'Hara BF, Osadchuk AV, Paigen B, Palmer AA, Peirce JL, Pomp D, Rosemann M, Rosen GD, Schalkwyk LC, Seltzer Z, Settle S, Shimomura K, Shou S, Sikela JM, Siracusa LD, Spearow JL, Teuscher C, Threadgill DW, Toth LA, Toye AA, Vadasz C, Van Zant G, Wakeland E, Williams RW, Zhang HG, Zou F: The nature and identification of quantitative trait loci: A community's view. Nat Rev Genet 4: 911-916, 2003
20. Morita T, Yamamoto T, Churg J: Mesangiolysis: An update. Am J Kidney Dis 31: 559-573, 1998
21. Bagchus WM, Hoedemaeker PJ, Rozing J, Bakker WW: Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies: A sequential histological and ultrastructural study in the rat. Lab Invest 55: 680-687, 1986
22. Eremina V, Cui S, Gerber H, Ferrara N, Haigh J, Nagy A, Ema M, Rossant J, Jothy S, Miner JH, Quaggin SE: Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol 17: 724-735, 2006
23. Esquivel E, Mollet G, Lavin TA, Ratelade J, Beau V, Ayadi A, Bugeon L, Gubler MC, and Antignac C: A novel mouse model of podocin inactivation in the adult mouse, using a tamoxifen-inducible cre recombinase, develops nephrotic syndrome and glomerulosclerosis [Abstract]. J Am Soc Nephrol 17: 24A, 2006
24. Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K, Hangan D, Ozaltin F, Zenker M, Hildebrandt F: Nephrotic syndrome in the first year of life: Two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 119: e907-e919, 2007
25. Wlodek ME, Mibus A, Tan A, Siebel AL, Owens JA, Moritz KM: Normal lactational environment restores nephron endowment and prevents hypertension after placental restriction in the rat. J Am Soc Nephrol 18: 1688-1696, 2007
26. Hamosh M: Bioactive factors in human milk. Pediatr Clin North Am 48: 69-86, 2001
27. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S: Identification of a factor that links apoptotic cells to phagocytes. Nature 417: 182-187, 2002
28. Silvestre JS, Thery C, Hamard G, Boddaert J, Aguilar B, Delcayre A, Houbron C, Tamarat R, Blanc-Brude O, Heeneman S, Clergue M, Duriez M, Merval R, Levy B, Tedgui A, Amigorena S, Mallat Z: Lactadherin promotes VEGF-dependent neovascularization. Nat Med 11: 499-506, 2005
29. Tang Y, McKinnon ML, Leong LM, Rusholme SA, Wang S, Akhurst RJ: Genetic modifiers interact with maternal determinants in vascular development of Tgfb1(-/-) mice. Hum Mol Genet 12: 1579-1589, 2003
30. Aubin-Houzelstein G, Da Silva NR, Bellier S, Salaun P, Montagutelli X, Panthier JJ: Genetic interaction between a maternal factor and the zygotic genome controls the intestine length in PRM/Alf mice. Physiol Genomics 16: 82-89, 2003
31. Putaala H, Soininen R, Kilpelainen P, Wartiovaara J, Tryggvason K: The murine nephrin gene is specifically expressed in kidney, brain and pancreas: Inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 10: 1-8, 2001
32. Ciani L, Patel A, Allen ND, ffrench-Constant C: Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype. Mol Cell Biol 23: 3575-3582, 2003
33. Doyonnas R, Kershaw DB, Duhme C, Merkens H, Chelliah S, Graf T, McNagny KM: Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. J Exp Med 194: 13-27, 2001
34. Donoviel DB, Freed DD, Vogel H, Potter DG, Hawkins E, Barrish JP, Mathur BN, Turner CA, Geske R, Montgomery CA, Starbuck M, Brandt M, Gupta A, Ramirez-Solis R, Zambrowicz BP, Powell DR: Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN. Mol Cell Biol 21: 4829- 4836, 2001
35. Hugo C, Shankland SJ, Bowen-Pope DF, Couser WG, Johnson RJ: Extraglomerular origin of the mesangial cell after injury: A new role of the juxtaglomerular apparatus. J Clin Invest 100: 786-794, 1997
36. Turner ST, Kardia SL, Mosley TH, Rule AD, Boerwinkle E, de Andrade M: Influence of genomic loci on measures of chronic kidney disease in hypertensive sibships. J Am Soc Nephrol 17: 2048-2055, 2006
37. Leon JM, Freedman BI, Miller MB, North KE, Hunt SC, Eckfeldt JH, Lewis CE, Kraja AT, Djousse L, Arnett DK: Genome scan of glomerular filtration rate and albuminuria: The HyperGEN study. Nephrol Dial Transplant 22: 763-771, 2007
38. Deen WM: What determines glomerular capillary permeability? J Clin Invest 114: 1412-1414, 2004
39. Birn H, Christensen EI: Renal albumin absorption in physiology and pathology. Kidney Int 69: 440-449, 2006
40. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001